360 filings
Page 6 of 18
4
Oron Assaf
3 Mar 23
BiomX / Assaf Oron ownership change
3:57pm
8-K
PHGE
BiomX Inc
27 Feb 23
Entry into a Material Definitive Agreement
5:10pm
8-K
PHGE
BiomX Inc
22 Feb 23
Revolutionizing the treatment of Cystic Fibrosis through our unique BOLT Phage therapy platform Investor Presentation / Jan 2023
3:05pm
SC 13G/A
PHGE
BiomX Inc
14 Feb 23
BiomX / MMCAP International Inc. SPC ownership change
12:53pm
SC 13G/A
Chidozie Ugwumba
13 Feb 23
BiomX / Ugwumba Chidozie ownership change
3:57pm
8-K
PHGE
BiomX Inc
26 Jan 23
Revolutionizing the treatment of Cystic Fibrosis through our unique BOLT Phage therapy platform Investor Presentation / Jan 2023
8:31am
8-K
PHGE
BiomX Inc
6 Jan 23
Departure of Directors or Certain Officers
4:30pm
4
Chidozie Ugwumba
14 Nov 22
BiomX / Chidozie Ugwumba ownership change
6:37pm
4
Chidozie Ugwumba
14 Nov 22
BiomX / Chidozie Ugwumba ownership change
6:17pm
4
Chidozie Ugwumba
14 Nov 22
BiomX / Chidozie Ugwumba ownership change
5:51pm
SC 13G/A
PHGE
BiomX Inc
14 Nov 22
BiomX / Ugwumba Chidozie ownership change
5:10pm
10-Q
2022 Q3
PHGE
BiomX Inc
Quarterly report
9 Nov 22
11:04am
8-K
PHGE
BiomX Inc
9 Nov 22
BiomX Reports Third Quarter 2022 Financial Results and Provides Business Update
7:25am
8-K
PHGE
BiomX Inc
29 Aug 22
Submission of Matters to a Vote of Security Holders
4:01pm
4
Wolfson Marina
24 Aug 22
BiomX / Marina Wolfson ownership change
4:04pm
4
Solomon Jonathan Eitan
24 Aug 22
BiomX / Jonathan Eitan Solomon ownership change
4:03pm
4
Merav Bassan
24 Aug 22
BiomX / Merav Bassan ownership change
4:01pm
10-Q
2022 Q2
PHGE
BiomX Inc
Quarterly report
10 Aug 22
2:10pm
8-K
PHGE
BiomX Inc
10 Aug 22
BiomX Reports Second Quarter 2022 Financial Results and Provides Business Update
12:00am
SC 13G/A
TAK
Takeda Pharmaceutical Co
5 Aug 22
BiomX / TAKEDA PHARMACEUTICAL ownership change
12:00am